341 related articles for article (PubMed ID: 28801056)
1. Clinical evaluation of the new Roche platform of serological and molecular cytomegalovirus-specific assays in the diagnosis and prognosis of congenital cytomegalovirus infection.
Chiereghin A; Pavia C; Gabrielli L; Piccirilli G; Squarzoni D; Turello G; Gibertoni D; Simonazzi G; Capretti MG; Lanari M; Lazzarotto T
J Virol Methods; 2017 Oct; 248():250-254. PubMed ID: 28801056
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform.
Revello MG; Vauloup-Fellous C; Grangeot-Keros L; van Helden J; Dickstein Y; Lipkin I; Mühlbacher A; Lazzarotto T
Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3331-9. PubMed ID: 22850741
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
[TBL] [Abstract][Full Text] [Related]
5. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
Rajasekariah H; Scott G; Robertson PW; Rawlinson WD
J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
[TBL] [Abstract][Full Text] [Related]
6. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
7. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.
Enders G; Bäder U; Lindemann L; Schalasta G; Daiminger A
Prenat Diagn; 2001 May; 21(5):362-77. PubMed ID: 11360277
[TBL] [Abstract][Full Text] [Related]
8. Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection.
Kaneko M; Ohhashi M; Minematsu T; Muraoka J; Kusumoto K; Sameshima H
J Infect Chemother; 2017 Mar; 23(3):173-176. PubMed ID: 28034524
[TBL] [Abstract][Full Text] [Related]
9. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection.
Sonoyama A; Ebina Y; Morioka I; Tanimura K; Morizane M; Tairaku S; Minematsu T; Inoue N; Yamada H
J Med Virol; 2012 Dec; 84(12):1928-33. PubMed ID: 23080498
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two Cobas Core enzyme immunoassays with other test systems for the detection of cytomegalovirus-specific IgG and IgM antibodies.
Steinmann J; Weigel T
J Clin Lab Anal; 1994; 8(4):191-9. PubMed ID: 7931812
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of Roche COBAS
Hildenbrand C; Wedekind L; Li G; vonRentzell JE; Shah K; Rooney P; Harrington AT; Zhao RY
J Med Virol; 2018 Oct; 90(10):1611-1619. PubMed ID: 29797374
[TBL] [Abstract][Full Text] [Related]
12. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
Prince HE; Leber AL
Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluation of the VIDAS(®) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation.
Vauloup-Fellous C; Berth M; Heskia F; Dugua JM; Grangeot-Keros L
J Clin Virol; 2013 Feb; 56(2):118-23. PubMed ID: 23182774
[TBL] [Abstract][Full Text] [Related]
14. The detection of CMV in amniotic fluid and cervicovaginal smear samples by real-time PCR assay in prenatal diagnosis.
Biri A; Bozdayi G; Ciçfti B; Dinç B; Yücel A; Rota S
Arch Gynecol Obstet; 2006 Feb; 273(5):261-6. PubMed ID: 16001197
[TBL] [Abstract][Full Text] [Related]
15. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection.
Torii Y; Yoshida S; Yanase Y; Mitsui T; Horiba K; Okumura T; Takeuchi S; Suzuki T; Kawada JI; Kotani T; Yamashita M; Ito Y
BMC Pregnancy Childbirth; 2019 Jun; 19(1):205. PubMed ID: 31221131
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Artus RotorGene and COBAS Ampliprep/COBAS TaqMan Platforms for the Detection of Cytomegalovirus: Experience of a Tertiary Care Center.
Hoteit R; Fermanian P; Abbas F; Abdel Khalek R; Mahfouz R
Genet Test Mol Biomarkers; 2016 Apr; 20(4):167-9. PubMed ID: 26841255
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the new LIAISON(®) CMV IgG, IgM and IgG Avidity II assays.
Delforge ML; Desomberg L; Montesinos I
J Clin Virol; 2015 Nov; 72():42-5. PubMed ID: 26395519
[TBL] [Abstract][Full Text] [Related]
18. Laboratory evaluation of the new Access ® cytomegalovirus immunoglobulin IgM and IgG assays.
Carlier P; Harika N; Bailly R; Vranken G
J Clin Virol; 2010 Nov; 49(3):192-7. PubMed ID: 20801078
[TBL] [Abstract][Full Text] [Related]
19. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
[TBL] [Abstract][Full Text] [Related]
20. Reconsideration of Maternal Serological Testing for Predicting Congenital CMV Infection.
Huang Y; Tang J; Yu H; Song Q; Hao M; Wang H; Liu J; Dong Y; Liang M; Zhuang S; Li C; Wang J; Liang C; Su Y; Li T; Wu T; Ge S; Zhang J; Xia N
J Infect Dis; 2024 Jun; 229(6):1817-1822. PubMed ID: 37738651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
